Trimethoprim/Sulfamethoxazole Remains Active Against Enterotoxigenic Escherichia coli and Shigella Species in Guadalajara, Mexico
Open Access
- 1 May 1992
- journal article
- research article
- Published by Elsevier in The Lancet Healthy Longevity
- Vol. 303 (5) , 289-291
- https://doi.org/10.1097/00000441-199205000-00003
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Emergence of resistant fecal Escherichia coli in travelers not taking prophylactic antimicrobial agentsAntimicrobial Agents and Chemotherapy, 1990
- Treatment of Traveler's Diarrhea With Sulfamethoxazole and Trimethoprim and LoperamidePublished by American Medical Association (AMA) ,1990
- Efficacy of trimethoprim-sulfamethoxazole in treatment of acute diarrhea in a Mexican pediatric populationThe Journal of Pediatrics, 1987
- Ciprofloxacin or Trimethoprim-Sulfamethoxazole as Initial Therapy for Travelers' DiarrheaAnnals of Internal Medicine, 1987
- In Vitro Activity of Ciprofloxacin Compared to Trimethoprim-Sulfamethoxazole against Campylobacter spp., Shigella spp. and Enterotoxigenic Escherichia coli Causing Travellers’ Diarrhea in EgyptScandinavian Journal of Infectious Diseases, 1987
- Resistance of Shigella, Salmonella, and Other Selected Enteric Pathogens to Antimicrobial AgentsClinical Infectious Diseases, 1986
- Comparative in vitro activities of ten antimicrobial agents against bacterial enteropathogensAntimicrobial Agents and Chemotherapy, 1983
- Treatment of Travelers' Diarrhea with Trimethoprim/Sulfamethoxazole and with Trimethoprim AloneNew England Journal of Medicine, 1982
- Emergence of High-Level Trimethoprim Resistance in FecalEscherichia coliduring Oral Administration of Trimethoprim or Trimethoprim-SulfamethoxazoleNew England Journal of Medicine, 1982
- Comparative Susceptibility of Latin American and United States Students to Enteric PathogensNew England Journal of Medicine, 1976